within Pharmacolibrary.Drugs.ATC.G;

model G03GA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 225 / 1000000,
    adminCount     = 1,
    Vd             = 0.0087,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Urofollitropin is a purified form of the follicle-stimulating hormone (FSH) derived from the urine of postmenopausal women. It is used in the treatment of infertility in women, particularly in assisted reproductive technologies such as in vitro fertilization (IVF), to stimulate the development of multiple follicles. The drug is approved and widely used in fertility treatments.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy female volunteers following subcutaneous administration.</p><h4>References</h4><ol><li><p>Porchet, HC, et al., &amp; Zanolo, G (1993). Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 21(1) 144–150. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8095209/&quot;>https://pubmed.ncbi.nlm.nih.gov/8095209</a></p></li><li><p>Di Stefano, AF, et al., &amp; Cometti, B (2016). Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin. <i>Clinical drug investigation</i> 36(12) 1031–1044. DOI:<a href=&quot;https://doi.org/10.1007/s40261-016-0451-6&quot;>10.1007/s40261-016-0451-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27638053/&quot;>https://pubmed.ncbi.nlm.nih.gov/27638053</a></p></li><li><p> (2003). Urofollitropin - Ferring: FERRING hFSH, hFSH - Ferring, human follicle-stimulating hormone - Ferring, Bravelle. <i>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</i> 17(4) 288–289. DOI:<a href=&quot;https://doi.org/10.2165/00063030-200317040-00008&quot;>10.2165/00063030-200317040-00008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12899646/&quot;>https://pubmed.ncbi.nlm.nih.gov/12899646</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03GA04;
